Cargando…
Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials
PURPOSE: We aimed to establish correlations between the clinical features of a cohort of Usher syndrome (USH) patients with pathogenic variants in MYO7A, type of pathogenic variant, and location on the protein domain. METHODS: Sixty‐two USH patients from 46 families with biallelic variants in MYO7A...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540557/ https://www.ncbi.nlm.nih.gov/pubmed/33576163 http://dx.doi.org/10.1111/aos.14795 |
_version_ | 1784803733319712768 |
---|---|
author | Galbis‐Martínez, Lilián Blanco‐Kelly, Fiona García‐García, Gema Ávila‐Fernández, Almudena Jaijo, Teresa Fuster‐García, Carla Perea‐Romero, Irene Zurita‐Muñoz, Olga Jimenez‐Rolando, Belén Carreño, Ester García‐Sandoval, Blanca Millán, José M. Ayuso, Carmen |
author_facet | Galbis‐Martínez, Lilián Blanco‐Kelly, Fiona García‐García, Gema Ávila‐Fernández, Almudena Jaijo, Teresa Fuster‐García, Carla Perea‐Romero, Irene Zurita‐Muñoz, Olga Jimenez‐Rolando, Belén Carreño, Ester García‐Sandoval, Blanca Millán, José M. Ayuso, Carmen |
author_sort | Galbis‐Martínez, Lilián |
collection | PubMed |
description | PURPOSE: We aimed to establish correlations between the clinical features of a cohort of Usher syndrome (USH) patients with pathogenic variants in MYO7A, type of pathogenic variant, and location on the protein domain. METHODS: Sixty‐two USH patients from 46 families with biallelic variants in MYO7A were examined for visual and audiological features. Participants were evaluated based on self‐reported ophthalmological history and ophthalmological investigations (computerized visual field testing, best‐corrected visual acuity, and ophthalmoscopic and electrophysiological examination). Optical coherence tomography and fundus autofluorescence imaging were performed when possible. Auditory and vestibular functions were evaluated. Patients were classified according to the type of variant and the protein domain where the variants were located. RESULTS: Most patients displayed a typical USH1 phenotype, that is, prelingual severe‐profound sensorineural hearing loss, prepubertal retinitis pigmentosa (RP) and vestibular dysfunction. No statistically significant differences were observed for the variables analysed except for the onset of hearing loss due to the existence of two USH2 cases, defined as postlingual sensorineural hearing loss, postpubertal onset of RP, and absence of vestibular dysfunction, and one atypical case of USH. CONCLUSION: We were unable to find a correlation between genotype and phenotype for MYO7A. However, our findings could prove useful for the assessment of efficacy in clinical trials, since the type of MYO7A variant does not seem to change the onset, severity or course of visual disease. |
format | Online Article Text |
id | pubmed-9540557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95405572022-10-14 Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials Galbis‐Martínez, Lilián Blanco‐Kelly, Fiona García‐García, Gema Ávila‐Fernández, Almudena Jaijo, Teresa Fuster‐García, Carla Perea‐Romero, Irene Zurita‐Muñoz, Olga Jimenez‐Rolando, Belén Carreño, Ester García‐Sandoval, Blanca Millán, José M. Ayuso, Carmen Acta Ophthalmol Original Articles PURPOSE: We aimed to establish correlations between the clinical features of a cohort of Usher syndrome (USH) patients with pathogenic variants in MYO7A, type of pathogenic variant, and location on the protein domain. METHODS: Sixty‐two USH patients from 46 families with biallelic variants in MYO7A were examined for visual and audiological features. Participants were evaluated based on self‐reported ophthalmological history and ophthalmological investigations (computerized visual field testing, best‐corrected visual acuity, and ophthalmoscopic and electrophysiological examination). Optical coherence tomography and fundus autofluorescence imaging were performed when possible. Auditory and vestibular functions were evaluated. Patients were classified according to the type of variant and the protein domain where the variants were located. RESULTS: Most patients displayed a typical USH1 phenotype, that is, prelingual severe‐profound sensorineural hearing loss, prepubertal retinitis pigmentosa (RP) and vestibular dysfunction. No statistically significant differences were observed for the variables analysed except for the onset of hearing loss due to the existence of two USH2 cases, defined as postlingual sensorineural hearing loss, postpubertal onset of RP, and absence of vestibular dysfunction, and one atypical case of USH. CONCLUSION: We were unable to find a correlation between genotype and phenotype for MYO7A. However, our findings could prove useful for the assessment of efficacy in clinical trials, since the type of MYO7A variant does not seem to change the onset, severity or course of visual disease. John Wiley and Sons Inc. 2021-02-11 2021-12 /pmc/articles/PMC9540557/ /pubmed/33576163 http://dx.doi.org/10.1111/aos.14795 Text en © 2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Galbis‐Martínez, Lilián Blanco‐Kelly, Fiona García‐García, Gema Ávila‐Fernández, Almudena Jaijo, Teresa Fuster‐García, Carla Perea‐Romero, Irene Zurita‐Muñoz, Olga Jimenez‐Rolando, Belén Carreño, Ester García‐Sandoval, Blanca Millán, José M. Ayuso, Carmen Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials |
title | Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials |
title_full | Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials |
title_fullStr | Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials |
title_full_unstemmed | Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials |
title_short | Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials |
title_sort | genotype–phenotype correlation in patients with usher syndrome and pathogenic variants in myo7a: implications for future clinical trials |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540557/ https://www.ncbi.nlm.nih.gov/pubmed/33576163 http://dx.doi.org/10.1111/aos.14795 |
work_keys_str_mv | AT galbismartinezlilian genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT blancokellyfiona genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT garciagarciagema genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT avilafernandezalmudena genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT jaijoteresa genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT fustergarciacarla genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT perearomeroirene genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT zuritamunozolga genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT jimenezrolandobelen genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT carrenoester genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT garciasandovalblanca genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT millanjosem genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials AT ayusocarmen genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials |